Business Wire

Transition Industries Awards Techint E&C and Siemens Energy a FEED Contract for a 210 MW Electrolyzer Facility for the Pacifico Mexinol Project

28.8.2025 16:00:00 EEST | Business Wire | Press release

Share

Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and hydrogen facilities, has awarded Siemens Energy and Techint Engineering & Construction a Front-End Engineering Design (FEED) contract for an approximately 210 MW Elyzer P-300 electrolyzer facility as part of its 6,130 MT per day ultra-low carbon methanol Pacifico Mexinol project in Sinaloa, Mexico.

The FEED study marks the next step in the expanding partnership between Transition Industries, Techint Engineering & Construction, and Siemens Energy, who intend to leverage their advanced technology and services to ensure the highest standards of efficiency and reliability in green hydrogen production. Under the terms of the FEED Agreement, Siemens Energy and Techint Engineering & Construction will provide an initial binding not-to-exceed Lump Sum Firm Price, followed by a final binding Lump Sum Turnkey Firm Price for the Engineering, Procurement and Construction (EPC) of the electrolyzer facility.

Once operational in 2029, Pacifico Mexinol is poised to be the largest standalone ultra-low carbon chemical production facility and one of the largest producers of green hydrogen and green methanol in the world.

Rommel Gallo, Transition Industries CEO, said: “This milestone marks a significant step forward in our mission to drive innovation and sustainability in the chemicals sector. Partnering with Siemens Energy and Techint E&C positions us to develop the hydrogen production element of our Pacifico Mexinol project, thereby reducing emissions and contributing to the global energy transition.”

The Hydrogen Plant will be designed to produce green hydrogen to support the growing demand for sustainable hydrogen. The FEED study will focus on optimizing the design, standardization, and engineering aspects of the Hydrogen Plant with an estimated production capacity of approximately 4,000 kg of hydrogen/hour with the highest safety, environmental and operational standards.

Siemens Energy, one of the world’s leading energy technology companies, was selected for this aspect of the project, capitalizing on their expertise in green hydrogen production. Siemens Energy’s Elyzer P-300 technology will play a crucial role in achieving the project’s goals of efficiency, sustainability, and scalability.

"At Techint E&C, we talk about a passion for doing, but even more so when it comes to challenging and high-impact projects like Mexinol, which are the ones that allow us to contribute with all our technical expertise, be part of a key energy transition project as the largest green hydrogen plant in America, and continue building a better future for everyone," highlighted Alejandro Maluf, President – North America Region, Techint E&C.

Transition Industries is jointly developing Pacifico Mexinol with the International Finance Corporation (IFC), a member of the World Bank Group. When it initiates operations in 2029, Pacifico Mexinol is expected to be the largest single ultra-low carbon methanol facility in the world – producing approximately 350,000 MT of green methanol and 1.8 million MT of blue methanol annually from natural gas with carbon capture.

ABOUT TRANSITION INDUSTRIES

Transition Industries LLC, based in Houston, Texas, is a developer of world-scale, net-zero carbon emissions methanol and green hydrogen projects in North America to address climate change and promote environmental and social sustainability. For additional information about Pacifico Mexinol or Transition Industries, email inquiries@transitionind.com.

ABOUT TECHINT

Techint Engineering & Construction is a global leader in project management, engineering, procurement, and construction across sectors such as Oil & Gas, Energy, Mining, and Industrial Plants. With over 75 years of experience and a team of more than 20,000 professionals worldwide, Techint is committed to executing highly complex projects with the highest standards of safety, quality, and environmental responsibility.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250828068284/en/

Contacts

Transition Industries Press Relations
Karin Nunan
Head of Corporate Affairs
knunan@transitionind.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Serbian Biotech Startup Takes Its Journey from Belgrade to Cambridge with Documentary on Longevity Science21.9.2026 14:02:00 EEST | Press release

BioEridan, a Serbian biotechnology startup backed by Telekom Srbija Group’s TS Ventures Fund, has premiered a new documentary showcasing its development of underwater Aquafarms and its ambition to contribute to the next generation of longevity science. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921345879/en/ BioEridan Documentary Premiere BioEridan: Science Beneath the Surface premiered in Belgrade on September 15 before being screened the following day at a UK-Serbia Health, Digital Transformation & Innovation roundtable held at Christ’s College, University of Cambridge, as part of Cambridge Tech Week 2026. The roundtable brought together prominent representatives from the UK and Serbia across science, healthcare, technology, academia and business to discuss opportunities for collaboration, innovation and the commercialisation of scientific research. The documentary follows BioEridan’s development from an early scien

LabVantage Named a Visionary Leader in Life Sciences and Industrial LIMS by Frost & Sullivan21.9.2026 11:30:00 EEST | Press release

LabVantage Solutions, Inc., a leading global provider of laboratory informatics solutions and services, has been named a Visionary Leader in two 2026 Frost Radar™ reports by Frost & Sullivan: Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026 and Frost Radar™: Laboratory Information Management Systems in Industrial Applications, 2026. Announced at LabVantage’s Customer Training and Education Conference (CTEC) Europe 2026 in Paris, the dual recognition marks LabVantage’s fourth consecutive year of Frost Radar leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921487430/en/ The Frost Radar is an independent benchmarking analysis that evaluates companies on a Growth Index and an Innovation Index. The Growth Index measures a company’s growth performance, track record, and ability to execute its growth strategy, while the Innovation Index assesses its ability to develop globally applicable solu

Bending Spoons opens office in Warsaw as Polish applications reach 50,000 in 202621.9.2026 10:15:00 EEST | Press release

Bending Spoons has opened an office in Warsaw, adding to its Milan headquarters and locations in London and Madrid. The technology company, whose portfolio includes Eventbrite and WeTransfer, has seen a sharp rise in applications from Poland and will use the new base to recruit locally for roles across key projects. “We’ve received around 50,000 applications from Poland so far this year, more than twice as many as the whole of 2025. What stands out isn’t just the volume. Many Polish candidates are among the strongest we see in our selection process, and the student talent has been particularly impressive. More than half of our recent hires from Poland were still studying when they applied,” says Andrea Maiorana, Talent data lead. Located in Śródmieście, Warsaw’s city center, the office is within walking distance of the Presidential Palace and the University of Warsaw. Bending Spoons encourages all new hires to spend their first few months in Milan, with travel and accommodation costs f

Strongest Half-Year in Curatis’s History — Revenue up 51% and Significant Progress on Corticorelin (C-PTBE-01)21.9.2026 08:03:00 EEST | Press release

Curatis Holding AG (SIX:CURN, “Curatis”) reports net sales from goods and services of CHF 7.9m for the first half of 2026, up 51% (H1 2025: CHF 5.2m), with the loss for the period narrowing to CHF -0.4m (H1 2025: CHF -1.2m) and cash and cash equivalents rising to CHF 3.6m (31 December 2025: CHF 1.9m). Curatis also advanced its corticorelin (C-PTBE-01) program on multiple levels, including an exclusive Japan licence with Neupharma and continued manufacturing progress. Business development and finances Net sales from goods increased by 46% to CHF 7.4m (H1 2025: CHF 5.0m) and net sales from services rose to CHF 0.6m (H1 2025: CHF 0.2m). Growth was driven both by products marketed for some time and by products added to the distribution portfolio in 2025 and 2026. The gross contribution from goods and services rose by 32% to CHF 1.8m (H1 2025: CHF 1.3m); the combined cost base grew by only 9% against net sales growth of 51%, as personnel expenses rose 5% to CHF 1.3m (H1 2025: CHF 1.2m) and

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies21.9.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland's leading blue chip equity benchmark comprising 20 of the country's largest and most liquid listed companies. Less than three years after its IPO on the SIX Swiss Exchange in March 2024, Galderma has established itself as one of Switzerland's leading listed companies. Its inclusion in the SMI reflects the company's strong growth, disciplined execution and increasing relevance in Swiss and international capital markets as it advances its ambition to become the world's leading dermatology powerhouse. Since its IPO, Galderma has continued to execute its growth-focused integrated dermatology strategy, delivering strong performance across Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Net sales increased from 4.410 billion USD in 2024 to 5.207 billion USD in 2025, driven by science-led innovation, portfolio and geogr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye